BRIEF-EMA Says Qalsody (Tofersen) Indicated For Treatment Of Adults With ALS

Feb 23 (Reuters) – EMA:

* EMA SAYS NEW TREATMENT FOR RARE MOTOR NEURONE DISEASE RECOMMENDED FOR APPROVAL

* EMA: RECOMMENDED GRANTING MARKETING AUTHORISATION FOR A NEW THERAPY TO TREAT ADULT PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS)

* EMA SAYS QALSODY (TOFERSEN) INDICATED FOR TREATMENT OF ADULTS WITH ALS, WHO HAVE MUTATION IN THE SUPEROXIDE DISMUTASE 1 (SOD1) GENE Source text for Eikon: Further company coverage: [ ] ([email protected])

(c) Copyright Thomson Reuters 2024. Click For Restrictions – https://agency.reuters.com/en/copyright.html